Labcyte Selects Chayon Laboratories as Exclusive Korean Distributor
“As we expand in Asia, Chayon will help us reach users in the growing genomics market. We feel that with the Labcyte platforms, Chayon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free. Chayon will also reach users in our established markets of pharmaceutical drug discovery, including compound management, high-throughput and secondary screening," said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc.
“We see a great potential market for low-volume transfer devices in Korea. We believe that the growing genomics markets, especially for gene expression, SNP analysis and RNAi, will find that the need for miniaturization is met particularly well by the Labcyte technologies. The superior advantages of the Labcyte products and our understanding of the potential user base in Korea sets up a situation where the customers will have optimal interactions with a local group while reaping the benefits of the best available technology,” said Mr. S. K. Kim, president of Chayon Laboratories.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.